<DOC>
	<DOCNO>NCT01651013</DOCNO>
	<brief_summary>The purpose study describe treatment receive outcomes patient metastatic colorectal cancer , percentage patient K-Ras mutation tumor , describe cost treatment . Information also collect regard risk factor , variable among treatment center patient , explorative analysis do try identify factor impact prognosis factor predict tolerability response treatment .</brief_summary>
	<brief_title>Observational Study Treatment Metastatic Colorectal Cancer Role K-Ras</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Histologic diagnosis colorectal carcinoma Metastatic disease Signed informed consent Prior treatment metastatic colorectal cancer Refusal incapability provide informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>